Influenza and COVID-19 vaccine
| Combination of | |
|---|---|
| Influenza vaccine | Vaccine |
| COVID-19 vaccine | Vaccine |
| Clinical data | |
| ATC code |
|
Influenza and COVID-19 vaccine is a combined messenger RNA vaccine (mRNA) for protection against influenza and COVID‑19. It contains mRNA molecules that encode the full-length, membrane-bound hemagglutinin glycoproteins of seasonal influenza virus types A (H1N1 and H3N2) and B (Victoria lineage), as well as parts of the SARS-CoV-2 spike protein, namely the membrane-bound, linked N-terminal domain and the receptor-binding domain. It is the first combined vaccine against influenza and COVID‑19.
The most common side effects include injection site pain, fatigue (tiredness), myalgia (muscle pain), arthralgia (joint pain), headache, chills, lymphadenopathy (swollen lymph nodes), nausea/vomiting, and pyrexia (fever).